Marina Botto

2.3k total citations · 1 hit paper
15 papers, 1.8k citations indexed

About

Marina Botto is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Marina Botto has authored 15 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Marina Botto's work include Complement system in diseases (4 papers), Acute Myeloid Leukemia Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Marina Botto is often cited by papers focused on Complement system in diseases (4 papers), Acute Myeloid Leukemia Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Marina Botto collaborates with scholars based in United Kingdom, Italy and United States. Marina Botto's co-authors include Mark Walport, Anne E. Bygrave, Pier Paolo Pandolfi, H. Terence Cook, Franz Petry, Michael Loos, E. Mary Thompson, Claudio Sorio, Daniele Lissandrini and Michael A. Klein and has published in prestigious journals such as Nature Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Marina Botto

14 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

1998 1.2k citations Marina Botto, Anne E. Bygrave et al. Nature Genetics profile →

Peers

Countries citing papers authored by Marina Botto

Since Specialization

Citations

This map shows the geographic impact of Marina Botto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Botto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Botto more than expected).

Fields of papers citing papers by Marina Botto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Botto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Botto. The network helps show where Marina Botto may publish in the future.

Co-authorship network of co-authors of Marina Botto

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Botto. A scholar is included among the top collaborators of Marina Botto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Botto. Marina Botto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients—a potential biomarker of disease activity 2017 ·Lara D. Veeken ·(unknown), (unknown), Francesco Carlucci, (unknown), Valentina Foschi, Marco Castelli, (unknown), H. Terence Cook, Liz Lightstone, Thomas Cairns, Matthew C. Pickering, Marina Botto	14
2	A Role for PML in Innate Immunity 2011 ·Genes & Cancer ·Andrea Lunardi, Mirella Gáboli, Marco Giorgio, Roberta Rivi, Anne E. Bygrave, Michael Antoniou, Dubravka Drabek, Elaine Dzierzak, Matteo Fagioli, Leonardo Salmena, Marina Botto, Carlos Cordon‐Cardo, Lucio Luzzatto, Pier Giuseppe Pelicci, Frank Grosveld, Pier Paolo Pandolfi	42
3	Gemcitabine and vinorelbine as third-line therapy in elderly patients (pts) with advanced breast cancer (ABC) pretreated with taxanes and anthracyclines 2007 ·Journal of Clinical Oncology ·Henry Botto, Marina Botto	2
4	Combination or irinotecan (I) and 5-fluorouracil, leucovorin (5 FU/LV) in first and second line treatment in elderly patients with metastatic colo-rectal cancer (MCRC) 2005 ·Journal of Clinical Oncology ·Henry Botto, Marina Botto	1
5	AA amyloid deposition is complement independent 2001 ·UCL Discovery (University College London) ·(unknown), (unknown), Marina Botto, Mark Walport, (unknown)	1
6	Complement facilitates early prion pathogenesis 2001 ·Nature Medicine ·Michael A. Klein, Pascal S. Kaeser, Petra Schwarz, Heiko Weyd, Ioannis Xénarios, Rolf M. Zinkernagel, Michael C. Carroll, J. Sjef Verbeek, Marina Botto, Mark Walport, Hector Molina, Ulrich Kalinke, Hans Acha‐Orbea, Adriano Aguzzi	249
7	Cutting Edge: C1q Protects Against the Development of Glomerulonephritis Independently of C3 Activation 1999 ·The Journal of Immunology ·Daniel A. Mitchell, Philip R. Taylor, H. Terence Cook, Jill Moss, Anne E. Bygrave, Mark Walport, Marina Botto	72
8	Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies breakdown → 1998 ·Nature Genetics ·Marina Botto, (unknown), Anne E. Bygrave, E. Mary Thompson, H. Terence Cook, Franz Petry, Michael Loos, Pier Paolo Pandolfi, Mark Walport	1163
9	Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans 1996 ·The Journal of Immunology ·Michael A. Naughton, Marina Botto, (unknown), George J. Alexander, J. M. Goldman, Mark Walport	62
10	Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line 1996 ·Blood ·Kathryn Nason-Burchenal, Domenica Gandini, Marina Botto, Janet Allopenna, (unknown), Nicholas C.P. Cross, JM Goldman, Ethan Dmitrovsky, PP Pandolfi	56
11	Cyclosporin in Behçet's disease: Results in 16 patients after 24 months of therapy 1994 ·Clinical Rheumatology ·Maria Luisa Pacor, Domenico Biasi, Claudio Lunardi, P. Cortina, Paola Caramaschi, Domenico Girelli, Marina Botto, (unknown), Giorgio Lombardo, Lisa Maria Bambara	21
12	Seronegative spondyloarthropathy associated with megarectum 1993 ·Clinical Rheumatology ·Paola Caramaschi, Domenico Biasi, Marina Botto, Anna Maria Stanzial, (unknown), (unknown), Antonio Carletto, Lisa Maria Bambara	1
13	Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes 1992 ·The Journal of Immunology ·Marina Botto, Daniele Lissandrini, Claudio Sorio, Mark Walport	84
14	[Methotrexate in the therapy of rheumatoid arthritis. Results in 30 patients]. 1992 ·PubMed ·Domenico Biasi, Paola Caramaschi, Antonio Carletto, Marina Botto, (unknown), (unknown), (unknown)	1
15	A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies 1990 ·Transfusion ·Carolyn M. Giles, Marina Botto, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact